Alderon Biosciences Inc is categorized under Commercial Biotechnical Research in Beaufort, NC and active since 1985.
Alderon Biosciences Inc was established in 1985, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Robert Henkens at the company’s single location by writing to 120 Turner St # A, Beaufort, North Carolina NC 28516 or by phoning (252) 646-1278. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Alderon Biosciences Inc |
| Contact Person: | Robert Henkens |
| Address: | 120 Turner St # A, Beaufort, North Carolina 28516 |
| Phone Number: | (252) 646-1278 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1985 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Alderon Biosciences Inc was started in 1985 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Robert Henkens for inquiries that concern Alderon Biosciences Inc by calling the company number (252) 646-1278, as your correspondence is most welcome. Additionally, the physical location of the single location of Alderon Biosciences Inc can be found at the coordinates 34.717891,-76.66506 as well as the street address 120 Turner St # A in Beaufort, North Carolina 28516.
For its online presence, you may visit Alderon Biosciences Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.